
AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
CNN
AstraZeneca's Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday.
The findings from the new Phase 3 trial, which included more than 32,000 participants, may boost confidence in the vaccine, which was originally developed by the University of Oxford. The trial showed that the vaccine was well-tolerated and identified no safety concerns, the company said. An independent committee "found no increased risk of thrombosis or events characterized by thrombosis among the 21,583 participants receiving at least one dose of the vaccine," according to AstraZeneca.
Janet Mills and her allies are counting on a gender gap to narrow Platner’s wide lead ahead of the June 9 primary to decide who will face incumbent Republican Sen. Susan Collins. They are betting that the unfiltered style that has brought Platner widespread attention as someone who could help Democrats reach young men will backfire with women.

As a shrinking number of Transportation Security Administration agents work to keep hourslong security lines moving despite not being paid, President Donald Trump stepped into the fray Saturday, announcing he will send Immigration and Customs Enforcement officers to airports by Monday if Congress doesn’t agree to a plan to end the partial government shutdown.











